The cross‐over trial executed by Palevitch et al involved fifty seven clients with migraine diagnosed by medical assessment (diagnostic requirements not specified) (Palevitch 1997). Contributors as younger as 9 decades aged (age range nine to sixty five many years) were being involved In spite of migraine owning distinct traits in younger persons